3-[(1S)-1-(dimethylamino)ethyl]phenol

We are 3-[(1S)-1-(dimethylamino)ethyl]phenol CAS:139306-10-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  3-[(1S)-1-(dimethylamino)ethyl]phenol
CAS.NO:  139306-10-8
Synonyms:
Rivastigmine Related Compound C
(S)-3-[1-(Dimethylamino)ethyl]phenol
(S)-3-(1-(Dimethylamino)ethyl)phenol

Molecular Formula:C10H15NO
Molecular Weight: 165.23200

Physical and Chemical Properties:
Density: 1.041g / cm3
Boiling point: 237.3ºC at 760mmHg
Melting point: 87-88ºC
Flash point: 93.6ºC
Refractive index: 1.539

Specification:
Appearance:  Off-white to light yellow powder
Purity:≥99%
Isomer Assay %: ≤0.5%
Water  K.F. %: ≤0.5%
Max single impurity:≤0.5%
Related substances:≤1.0%
Residue on ignition：≤0.2%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Rivastigmine tartrate CAS:129101-54-8
Intermediates of Rivastigmine CAS:123441-03-2

Related News: Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.121219-12-3 Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.cetona de frambuesa CAS:5471-51-2 Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.(6-phenylnaphthalen-2-yl)boronic acid CAS:876442-90-9 Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.